1: Husain T, Shoaib MH, Yousuf RI, Maboos M, Khan M, Bashir L, Naz S. Formulation development and comparative in vitro study of metoprolol tartrate (IR) tablets. Pak J Pharm Sci. 2016 May;29(3):853-60. PubMed PMID: 27166530.
2: Zhao S, Yu F, Liu N, Di Z, Yan K, Liu Y, Li Y, Zhang H, Yang Y, Yang Z, Li Z, Mei X. Synchronous delivery of felodipine and metoprolol tartrate using monolithic osmotic pump technology. Drug Dev Ind Pharm. 2016 Apr 13:1-9. [Epub ahead of print] PubMed PMID: 27074758.
3: Emami J, Kazemali MR. Design and in vitro evaluation of a novel controlled onset extended-release delivery system of metoprolol tartrate. Res Pharm Sci. 2016 Jan-Feb;11(1):81-92. PubMed PMID: 27051436; PubMed Central PMCID: PMC4794941.
4: Aleksovski A, Van Bockstal PJ, Roškar R, Sovány T, Regdon G Jr, De Beer T, Vervaet C, Dreu R. Comparison of metoprolol tartrate multiple-unit lipid matrix systems produced by different technologies. Eur J Pharm Sci. 2016 Jun 10;88:233-45. doi: 10.1016/j.ejps.2016.03.011. Epub 2016 Mar 12. PubMed PMID: 26980237.
5: Li QL, Wang F, Wang JF, Zang HC, Zhang H, Jiang W. [Identification of Metoprolol Tartrate Tablets from Different Manufacturers by Different Near Infrared Spectrometers]. Guang Pu Xue Yu Guang Pu Fen Xi. 2015 Oct;35(10):2924-9. Chinese. PubMed PMID: 26904845.
6: Mehta R, Teckoe J, Schoener C, Workentine S, Ferrizzi D, Rajabi-Siahboomi A. Investigation into the Effect of Ethylcellulose Viscosity Variation on the Drug Release of Metoprolol Tartrate and Acetaminophen Extended Release Multiparticulates-Part I. AAPS PharmSciTech. 2016 Jan 7. [Epub ahead of print] PubMed PMID: 26743642.
7: Ijaz H, Qureshi J, Danish Z, Zaman M, Abdel-Daim M, Hanif M, Waheed I, Mohammad IS. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate. Pak J Pharm Sci. 2015 Nov;28(6):2019-25. PubMed PMID: 26639495.
8: Biswas N, Sahoo RK. Tapioca starch blended alginate mucoadhesive-floating beads for intragastric delivery of Metoprolol Tartrate. Int J Biol Macromol. 2016 Feb;83:61-70. doi: 10.1016/j.ijbiomac.2015.11.039. Epub 2015 Dec 1. PubMed PMID: 26592698.
9: Reddy RB, More KR, Gupta L, Jha MS, Magar L. Identification, synthesis, isolation and characterization of new impurity in metoprolol tartrate tablets. J Pharm Biomed Anal. 2016 Jan 5;117:104-8. doi: 10.1016/j.jpba.2015.08.039. Epub 2015 Aug 30. PubMed PMID: 26344385.
10: Abou El Ela Ael S, Khatib MM. Formulation and evaluation of new long acting metoprolol tartrate ophthalmic gels. Saudi Pharm J. 2014 Dec;22(6):555-63. doi: 10.1016/j.jsps.2014.03.003. PubMed PMID: 25561869; PubMed Central PMCID: PMC4281596.
11: Challa SR, Challa VR, Ragam SK. Quercetin declines plasma exposure of metoprolol tartrate in the rat model. J Adv Pharm Technol Res. 2014 Oct;5(4):185-90. doi: 10.4103/2231-4040.143038. PubMed PMID: 25364697; PubMed Central PMCID: PMC4215482.
12: Randhawa SK, Elliott WJ. Therapy: atenolol versus metoprolol tartrate--conflicting outcomes data. Nat Rev Nephrol. 2014 Nov;10(11):617-8. doi: 10.1038/nrneph.2014.164. Epub 2014 Sep 9. PubMed PMID: 25201142.
13: Vranic BZ, Vandamme TF. Preliminary study of an offline simultaneous determination of metoprolol tartrate and hydrochlorothiazide in powders and tablets by reflectance near-infrared spectroscopy. Pharm Dev Technol. 2015 Jan;20(1):99-104. doi: 10.3109/10837450.2014.949268. Epub 2014 Aug 14. PubMed PMID: 25118590.
14: Li N, Li CL, Lu NW, Dong YM. A novel micellar per aqueous liquid chromatographic method for simultaneous determination of diltiazem hydrochloride, metoprolol tartrate and isosorbide mononitrate in human serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Sep 15;967:90-7. doi: 10.1016/j.jchromb.2014.07.019. Epub 2014 Jul 21. PubMed PMID: 25086418.
15: Fleet JL, Weir MA, McArthur E, Ozair S, Devereaux PJ, Roberts MA, Jain AK, Garg AX. Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults. Am J Kidney Dis. 2014 Dec;64(6):883-91. doi: 10.1053/j.ajkd.2014.06.009. Epub 2014 Jul 16. PubMed PMID: 25037562.
16: Kostova B, Ivanova S, Balashev K, Rachev D, Christova D. Evaluation of poly(2-ethyl-2-oxazoline) containing copolymer networks of varied composition as sustained metoprolol tartrate delivery systems. AAPS PharmSciTech. 2014 Aug;15(4):939-46. doi: 10.1208/s12249-014-0120-0. Epub 2014 May 3. PubMed PMID: 24789663; PubMed Central PMCID: PMC4113615.
17: Abou el Ela Ael S, Allam AA, Ibrahim EH. Pharmacokinetics and anti-hypertensive effect of metoprolol tartrate rectal delivery system. Drug Deliv. 2016;23(1):69-78. doi: 10.3109/10717544.2014.904021. Epub 2014 Apr 24. PubMed PMID: 24758140.
18: Hamadeh IS, Langaee TY, Dwivedi R, Garcia S, Burkley BM, Skaar TC, Chapman AB, Gums JG, Turner ST, Gong Y, Cooper-DeHoff RM, Johnson JA. Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate. Clin Pharmacol Ther. 2014 Aug;96(2):175-81. doi: 10.1038/clpt.2014.62. Epub 2014 Mar 17. PubMed PMID: 24637943; PubMed Central PMCID: PMC4111800.
19: Khaled AA, Pervaiz K, Karim S, Farzana K, Murtaza G. Development of in vitro-in vivo correlation for encapsulated metoprolol tartrate. Acta Pol Pharm. 2013 Jul-Aug;70(4):743-7. PubMed PMID: 23923398.
20: Khan S, Gajbhiye C, Singhavi DJ, Yeole P. In situ Gel of Metoprolol Tartrate: Physicochemical Characterization, In vitro Diffusion and Histological Studies. Indian J Pharm Sci. 2012 Nov;74(6):564-70. doi: 10.4103/0250-474X.110608. PubMed PMID: 23798784; PubMed Central PMCID: PMC3687928.